Series B

Medici Brands just raised $250M, but the story isn't the money. It's the hidden tech platform, built on a proprietary fat substitute, that's upending CPG.

As AI pushes traditional networks to their breaking point, a Valencia-based startup lands a huge Series B to commercialize its programmable optical switches.

A Santa Clara startup just secured $30M from a single investor. Their goal: use AI to fix a critical bottleneck that slows down all of tech.

With a fresh $20M, Standard Metrics is arming VCs with AI. We dig into whether its platform is just another tool or a true revolution in transparency.

The custom rug disruptor just raised $20M. But its real power play lies in a new NYC HQ and key hires from Peloton, revealing a strategy to own the market.

AI video platform Higgsfield raises $400M at a $5.4B valuation, hitting $700M in revenue as it aims to reshape the multi-trillion-dollar media market.

Fortress Biotech's Q2 net loss masks a cash-rich strategy. A $117M cash surge and major pipeline wins reveal a model built for the long haul.

With a massive Series B and the launch of a Phase 3 study, Vaderis Therapeutics is poised to deliver the first-ever approved therapy for a long-neglected rare disease.

With a new CFO and a massive infusion of public and private cash, Multibeam is scaling up. Here’s how its unique tech is becoming a cornerstone of the US CHIPS Act.

Meduloc's $4M Series B, led by GenHenn Capital and backed by Andre Ethier, fuels the launch of its innovative nitinol implant for better fracture healing.

With $350M+ in funding, Acrab is challenging cloud giants with custom silicon for powerful local AI. This is their strategy to own the agentic AI future.

Expedition Therapeutics lands a huge Series B and starts a pivotal trial for a drug that could finally target the root cause of COPD for millions.

With a fresh $37M, WindBorne Systems is scaling its fleet of AI-guided balloons to create a new intelligence layer for our weather-dependent world.

With a strategic investment from UMass Memorial Health, Wellinks is scaling its predictive tech to prevent crises before they start. A new model for chronic care.

With $100M in total funding, bioinformatics firm Inocras plans to challenge U.S. precision oncology leaders by leveraging its whole-genome sequencing success in Asia.

South Korean robotic hand specialist Tesollo targets a post-2027 IPO, fueled by strategic Series B funding and a mission to dominate industrial automation.

With a massive $113M Series B, Onyx Security is tackling enterprise AI's biggest risk: unaccountable agents. It's a bet on a new security category.

With backing from Galaxy, Coinbase, and Franklin Templeton, Soter Insure is building the risk management infrastructure that could finally bring Wall Street to crypto.

With $26M in new funding, Epitel is scaling its wireless, AI-powered EEG system, aiming to revolutionize seizure diagnosis and bridge a critical care gap.

Palo Alto's Atropos Health just published 12 studies in six months using AI, revealing insights on everything from GLP-1s to Crohn's. It's a new paradigm for medicine.